Dallas Company To Develop Microbial Genome Scanning Tool for Vaccine Discovery | GenomeWeb

NEW YORK, Feb 8 – Eliance Biotechnology of Dallas has gained exclusive rights to develop large-scale genetic screening technology from The Center for Biomedical Inventions at University of Texas Southwestern Medical Center, the university announced Thursday.

The technology, called “Expression Library Immunization,” is designed to screen bacterial and viral genomes for vaccines and other agents with potential immunological value.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.